These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
286 related articles for article (PubMed ID: 22860766)
1. Fatty acid synthase regulates proliferation and migration of colorectal cancer cells via HER2-PI3K/Akt signaling pathway. Li N; Bu X; Tian X; Wu P; Yang L; Huang P Nutr Cancer; 2012 Aug; 64(6):864-70. PubMed ID: 22860766 [TBL] [Abstract][Full Text] [Related]
2. The "HER2-PI3K/Akt-FASN Axis" regulated malignant phenotype of colorectal cancer cells. Li N; Bu X; Wu P; Wu P; Huang P Lipids; 2012 Apr; 47(4):403-11. PubMed ID: 22218925 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro. Wang TF; Wang H; Peng AF; Luo QF; Liu ZL; Zhou RP; Gao S; Zhou Y; Chen WZ Biochem Biophys Res Commun; 2013 Oct; 440(2):229-34. PubMed ID: 24041695 [TBL] [Abstract][Full Text] [Related]
4. Loss of fatty acid synthase suppresses the malignant phenotype of colorectal cancer cells by down-regulating energy metabolism and mTOR signaling pathway. Chang L; Wu P; Senthilkumar R; Tian X; Liu H; Shen X; Tao Z; Huang P J Cancer Res Clin Oncol; 2016 Jan; 142(1):59-72. PubMed ID: 26109148 [TBL] [Abstract][Full Text] [Related]
5. Lapatinib alters the malignant phenotype of osteosarcoma cells via downregulation of the activity of the HER2-PI3K/AKT-FASN axis in vitro. Long XH; Zhang GM; Peng AF; Luo QF; Zhang L; Wen HC; Zhou RP; Gao S; Zhou Y; Liu ZL Oncol Rep; 2014 Jan; 31(1):328-34. PubMed ID: 24172910 [TBL] [Abstract][Full Text] [Related]
6. Loss of fatty acid synthase inhibits the "HER2-PI3K/Akt axis" activity and malignant phenotype of Caco-2 cells. Li N; Lu H; Chen C; Bu X; Huang P Lipids Health Dis; 2013 Jun; 12():83. PubMed ID: 23725225 [TBL] [Abstract][Full Text] [Related]
7. Growth suppression of HER2-overexpressing breast cancer cells by berberine via modulation of the HER2/PI3K/Akt signaling pathway. Kuo HP; Chuang TC; Yeh MH; Hsu SC; Way TD; Chen PY; Wang SS; Chang YH; Kao MC; Liu JY J Agric Food Chem; 2011 Aug; 59(15):8216-24. PubMed ID: 21699261 [TBL] [Abstract][Full Text] [Related]
8. LY294002 inhibits the malignant phenotype of osteosarcoma cells by modulating the phosphatidylinositol 3‑kinase/Akt/fatty acid synthase signaling pathway in vitro. Zhou Y; Zhu LB; Peng AF; Wang TF; Long XH; Gao S; Zhou RP; Liu ZL Mol Med Rep; 2015 Feb; 11(2):1352-7. PubMed ID: 25351625 [TBL] [Abstract][Full Text] [Related]
9. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification. Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro. Liu ZL; Mao JH; Peng AF; Yin QS; Zhou Y; Long XH; Huang SH Mol Med Rep; 2013 Feb; 7(2):608-12. PubMed ID: 23229760 [TBL] [Abstract][Full Text] [Related]
11. Interaction between fatty acid synthase- and ErbB-systems in ovarian cancer cells. Grunt TW; Wagner R; Grusch M; Berger W; Singer CF; Marian B; Zielinski CC; Lupu R Biochem Biophys Res Commun; 2009 Jul; 385(3):454-9. PubMed ID: 19467222 [TBL] [Abstract][Full Text] [Related]
12. Fatty acid synthase and AKT pathway signaling in a subset of papillary thyroid cancers. Uddin S; Siraj AK; Al-Rasheed M; Ahmed M; Bu R; Myers JN; Al-Nuaim A; Al-Sobhi S; Al-Dayel F; Bavi P; Hussain AR; Al-Kuraya KS J Clin Endocrinol Metab; 2008 Oct; 93(10):4088-97. PubMed ID: 18682509 [TBL] [Abstract][Full Text] [Related]
13. Mollugin inhibits proliferation and induces apoptosis by suppressing fatty acid synthase in HER2-overexpressing cancer cells. Do MT; Hwang YP; Kim HG; Na M; Jeong HG J Cell Physiol; 2013 May; 228(5):1087-97. PubMed ID: 23065756 [TBL] [Abstract][Full Text] [Related]
14. Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Tomek K; Wagner R; Varga F; Singer CF; Karlic H; Grunt TW Mol Cancer Res; 2011 Dec; 9(12):1767-79. PubMed ID: 21970855 [TBL] [Abstract][Full Text] [Related]
15. Positive feedback regulation between Akt phosphorylation and fatty acid synthase expression in osteosarcoma. Wang H; Luo QF; Peng AF; Long XH; Wang TF; Liu ZL; Zhang GM; Zhou RP; Gao S; Zhou Y; Chen WZ Int J Mol Med; 2014 Mar; 33(3):633-9. PubMed ID: 24366211 [TBL] [Abstract][Full Text] [Related]
16. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway. Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745 [TBL] [Abstract][Full Text] [Related]
17. Magnolol down-regulates HER2 gene expression, leading to inhibition of HER2-mediated metastatic potential in ovarian cancer cells. Chuang TC; Hsu SC; Cheng YT; Shao WS; Wu K; Fang GS; Ou CC; Wang V Cancer Lett; 2011 Dec; 311(1):11-9. PubMed ID: 21757288 [TBL] [Abstract][Full Text] [Related]
18. Inositol hexaphosphate suppresses growth and induces apoptosis in HT-29 colorectal cancer cells in culture: PI3K/Akt pathway as a potential target. Liu G; Song Y; Cui L; Wen Z; Lu X Int J Clin Exp Pathol; 2015; 8(2):1402-10. PubMed ID: 25973024 [TBL] [Abstract][Full Text] [Related]
19. Leptin receptor expression in Middle Eastern colorectal cancer and its potential clinical implication. Uddin S; Bavi PP; Hussain AR; Alsbeih G; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Ahmed M; Al-Kuraya KS Carcinogenesis; 2009 Nov; 30(11):1832-40. PubMed ID: 19520793 [TBL] [Abstract][Full Text] [Related]
20. Cycle arrest and apoptosis in MDA-MB-231/Her2 cells induced by curcumin. Sun SH; Huang HC; Huang C; Lin JK Eur J Pharmacol; 2012 Sep; 690(1-3):22-30. PubMed ID: 22705896 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]